Tofacitinib Devatis 5 mg, Filmtabletten - 56 Swissmedic Key 69213001 Registration Holder Devatis AG Name Tofacitinib Devatis 5 mg, Filmtabletten Date of registration 19.06.2025 Introduction of Sequence 19.06.2025 ATC-Classification (L04AF01) Revision date WHO WHO-DDD Valid until 18.06.2030 Index Therapeuticus (BSV) Show package size 56 Index Therapeuticus (Swissmedic) 07.15. Description Swissmedic categorie. B SL Eintrag No Indication Information for professionals IP Consumer information CI Ex-factory-Price PR Deductible k.A. Consumer price PR Feedback FB GTIN 7680692130013 Medication Code Synthetika Pharmacode Disponibility
Composition tofacitinibum 5 mg ut tofacitinibi citras, cellulosum microcristallinum, lactosum monohydricum, carmellosum natricum conexum corresp. natrium 0.54 mg, magnesii stearas, Überzug: hypromellosum, E 171, lactosum monohydricum, macrogolum 3350, triacetinum, pro compresso obducto corresp. lactosum monohydricum 62.57 mg. Packungsbestandteile Galenic Form Coated tablets Active Agent Dose Tofacitinibum 5 mg
Inactive agents Dose additional_information Carmellosum Natricum Conexum Cellulosum Microcristallinum E 171 color. Hypromellosum Überzug Lactose Monohydrate Macrogol 3350 Magnesii Stearas Pro Compresso Obducto Triacetinum
Source Data was imported : 11.07.2025
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
